|
Evaluating collagen neoepitopes as pharmacodynamic biomarkers of GS-5745, an MMP9 inhibitor, in advanced gastric cancer. |
| |
|
Employment - Gilead Sciences; OncoMed (I) |
Stock and Other Ownership Interests - Celgene; Gilead Sciences; OncoMed (I) |
| |
|
Employment - Amgen; Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
Travel, Accommodations, Expenses - Amgen; Gilead Sciences |
| |
|
No Relationships to Disclose |
| |
|
Employment - Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
| |
|
Employment - Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
| |
|
Employment - Gilead Sciences |
Stock and Other Ownership Interests - Gilead Sciences |
| |
|
Employment - Genentech; Gilead Sciences |
Stock and Other Ownership Interests - Genentech; Gilead Sciences |
| |
|
Employment - Amgen; Gilead Sciences |
Leadership - Gilead Sciences |
Stock and Other Ownership Interests - Amgen; Gilead Sciences |